Showing results (221-230 of 498) with videos related to
Sort By:
Pageof 50
Virus Evolution|October 25, 2016
Driving forces behind the evolution of the Aleutian mink disease parvovirus in the context of intensive farmingMarta Canuti, Kimberly E O'Leary, Bruce D Hunter, et al.Applied Microbiology|December 1, 1972
Anticapsin, a new biologically active metabolite: screening and assay proceduresJ G Whitney, S S Funderburk, J E Westhead, et al.Respiratory Research|November 26, 2009
Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in micePatrick C Reading, Danielle L Pickett, Michelle D Tate, et al.Antimicrobial Agents and Chemotherapy|October 19, 2000
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniaeJ H Jorgensen, L M Weigel, J M Swenson, et al.Journal of American College Health : J of ACH|April 19, 2003
Rapid response to a conjunctivitis outbreak: the use of technology to leverage informationJohn H Pryor, Michael T Martin, Cynthia G Whitney, et al.Vaccine|April 25, 2020
Characterization of pneumococcal meningitis before and after introduction of 13-valent pneumococcal conjugate vaccine in Niger, 2010-2018Sani Ousmane, Miwako Kobayashi, Issaka Seidou, et al.Journal of Microbiological Methods|May 22, 2007
An in vitro model to assess pneumococcal adherence to nasopharyngeal cells under competition conditionsGowrisankar Rajam, Delois Jackson, Tamara Pilishvili, et al.Vaccine|April 3, 2010
A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccinationThierry Van Effelterre, Matthew R Moore, Frederik Fierens, et al.Current Research in Microbial Sciences|December 15, 2022
Distinct epidemiological profiles of porcine circovirus 3 and fox circovirus in Canadian foxes (Vulpes spp.)Marta Canuti, Bruce Rodrigues, Émilie Bouchard, et al.Vaccine|June 23, 2007
Herd immunity and pneumococcal conjugate vaccine: a quantitative modelMichael Haber, Albert Barskey, Wendy Baughman, et al.Pageof 50